No Detail Found!

Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population.

Author(s)
Aisha Siddiqi Army Medical College (AMC), Rawalpindi, Pakistan
Dilshad Ahmad Khan Army Medical College (AMC), Rawalpindi, Pakistan
Farooq Ahmed Khan Army Medical College (AMC), Rawalpindi, Pakistan
Abdul Khaliq Naveed Department of Pathology, Department of Biochemistry, Army Medical College Rawalpindi National University of Sciences and Technology, Islamabad, Pakistan
Abstract
Variations of cytochrome-P450 enzyme system (CYP2CP) are associated with impaired metabolism of warfarin. The objective of our study was to estimate the frequency of genetic and allelic variants of CYP2C9 in Punjabi population of Pakistan and their effects on warfarin dose requirement. One hundred and twenty unrelated Pakistani subjects belong to Punjab province, were randomly included from the registry of National Institute of Heart Disease Rawalpindi, Pakistan. The patients had stable international normalized ratio (INR) of 2 to 3 for last 3 months with warfarin therapy after heart valves replacement. The detection of CYP2C9 variant was done on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Total 120 patients (73 males; 47 females) of mean age of 37 years participated in the study. Nine patients had mutant allele CYP2C9*3 (7.5%), one CYP2C9*2 (0.8%) and 110 patients exhibited wild type CYP2C9*1 (91.7%).The frequency of CYP2C9 genotype was *1/*1 (0.858) ; *1/*3 (0.117) ; 2/*20 (0.08) and *3/*3 (0.017) in our study population. A high dose of warfarin (42.2+9.56) mg/week is required for patients with *1/*1 genotype as compared to patients with *2/*2 (17.5+1.9) and *1/*3 (16.6+2.3) allele (p
Publication Details
Page(s) 417-422
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 23, Issue: 4, Year: 2010

Request the full text from PASTIC

0

Citations

0

Downloads

91

Views